Cellenion and SCIENION are now ONE. Transforming precision into progress.
Scaling research into real-world impact.
Lateral flow is a rapid, simple, and low-cost diagnostic technology widely used for point-of-care testing. It works by allowing a liquid sample to migrate along a membrane strip, where immobilized reagents capture target molecules, producing a visible result typically within minutes. Many are familiar with lateral flow through common applications, such as pregnancy testing and COVID-19 rapid antigen testing.
Lateral flow is widely used due to its accessibility. Tests are portable, requiring little to no specialized equipment, and can be performed by non-experts, making them easy to use in clinical, home, and field settings. This has driven widespread adoption across healthcare, women’s health, infectious disease testing, veterinary diagnostics, and environmental monitoring. As well as being simple and affordable, lateral flow assays provide results in real-time, supporting fast decision-making.
SCIENION’s non-contact microdispensing enables reliable, high-performance lateral flow assays for infectious disease detection and clinical testing.From influenza to COVID-19, precise reagent placement ensures reproducible, sensitive, and scalable diagnostics, supporting rapid, point-of-care decision-making in hospitals, clinics, and at home.
By combining sciFLEXARRAYER precision spotting with advanced membranes such as Sartorius’ Unisart StructSure®, next-generation lateral flow systems can detect multiple biomarkers in a single test.This evolution transforms qualitative strips into quantitative, high-content assays for personalized medicine and advanced disease management.
Beyond clinical use, SCIENION’s precision dispensing powers rapid, field-deployable assays for food safety, water quality, and women’s health.With consistent spotting and low-volume reagent use, reliable lateral flow tests are accessible even in low-resource or on-site environments, ensuring global impact and affordability.
